Dr Reddy S Laboratories Ltd
- All
- News
- Videos
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Dr Reddy's Says Made-In-India Sputnik V Doses To Be Available From September-October
Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said on Tuesday.
-
Sputnik V COVID-19 Vaccine Safe In India Mid-Stage Trial: Dr Reddy's
Dr Reddy's Laboratories Ltd said on Monday an independent board found Russia's Sputnik V COVID-19 vaccine to be safe in its mid-stage trial in India, and recommended progressing to late-stage trials.
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
-
Trials For Russia's Vaccine To Start In India In Next Few Weeks: Official
Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Dr Reddy's Says Made-In-India Sputnik V Doses To Be Available From September-October
Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said on Tuesday.
-
Sputnik V COVID-19 Vaccine Safe In India Mid-Stage Trial: Dr Reddy's
Dr Reddy's Laboratories Ltd said on Monday an independent board found Russia's Sputnik V COVID-19 vaccine to be safe in its mid-stage trial in India, and recommended progressing to late-stage trials.
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
-
Trials For Russia's Vaccine To Start In India In Next Few Weeks: Official
Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.
